Please use this identifier to cite or link to this item:
http://hdl.handle.net/10668/4414
Title: | Implementing Personalized Medicine in COVID-19 in Andalusia: An Opportunity to Transform the Healthcare System |
Authors: | Dopazo, Joaquín Maya-Miles, Douglas García, Federico Lorusso, Nicola Calleja, Miguel Ángel Pareja, María Jesús López-Miranda, José Rodríguez-Baño, Jesús Padillo, Javier Túnez, Isaac Romero-Gómez, Manuel |
metadata.dc.contributor.authoraffiliation: | [Dopazo,J; García,F; Lorusso,N; Calleja,MA; Pareja,MJ; López-Miranda,J; Rodríguez-Baño,J; Padillo,J; Túnez,I; Romero-Gómez,M] GT MP Covid-19. SGIDIS, Consejería de Salud y Familias, Junta de Andalucía, Spain. [Dopazo,J] Área de Bioinformática, Fundación progreso y Salud, Junta de Andalucía, Sevilla, Spain. [Dopazo,J] Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain. [Maya-Miles,D; Rodríguez-Baño,J; Padillo,J; Romero-Gómez,M] Instituto de Biomedicina de Sevilla (HUVR/HUVM/CSIC/US), Sevilla, Spain. [Maya-Miles,D; Romero-Gómez,M] Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain. [García,F] Servicio de Microbiología, Hospital Universitario San Cecilio, Granada, Spain. [García,F] Instituto de Investigación Biosanitaria IBS, Granada, Spain. [Lorusso,N] Dirección General de Salud Pública, Consejería de Salud y Familias, Junta de Andalucía, Spain. [Calleja,MA] Servicio de Farmacia, Hospital Universitario Virgen Macarena, Sevilla, Spain. [Pareja,MJ] Hospital Universitario de Valme, Sevilla, Spain. [López-Miranda,J; Túnez,I] Servicio de Medicina Interna, Hospital Universitario Reina Sofía, Córdoba, Spain. [López-Miranda,J; Túnez,I] Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain. [López-Miranda,J] Departamento de Ciencias Médicas y Quirúrgicas, Universidad de Córdoba, Córdoba, Spain. [Rodríguez-Baño,J] Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Sevilla, Spain. [Rodríguez-Baño,J; Romero-Gómez,M] Departamento de Medicina, Universidad de Sevilla, Sevilla, Spain. [Padillo,J] Departamento de Cirugía, Universidad de Sevilla, Sevilla, Spain. [Padillo,J] Servicio de Cirugía General y Digestiva, Hospital Universitario Virgen del Rocío, Sevilla, Spain. [Túnez,I] Departamento de Bioquímica, Universidad de Córdoba, Córdoba, Spain. [Túnez,I] Secretaría General de Investigación, Desarrollo e Innovación en Salud, Consejería de Salud y Familias de la Junta de Andalucía, Sevilla, Spain. [Romero-Gómez,M] Servicio de Aparato Digestivo, Hospital Universitario Virgen del Rocío, Sevilla, Spain |
Keywords: | Personalized medicine;Precision medicine;Covid-19;SARS CoV2;Epidemiology;Host genetics;Viral genome;Public health;Health care;Vaccination;Medicina de precisión;Epidemiología;Genoma viral;Atención a la salud;Vacunación |
metadata.dc.subject.mesh: | Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans Medical Subject Headings::Diseases::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections Medical Subject Headings::Health Care::Environment and Public Health::Public Health::Disease Outbreaks::Epidemics::Pandemics Medical Subject Headings::Chemicals and Drugs::Nucleic Acids, Nucleotides, and Nucleosides::Nucleic Acids::RNA::RNA, Viral Medical Subject Headings::Disciplines and Occupations::Health Occupations::Medicine::Public Health Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Asymptomatic Diseases::Asymptomatic Infections Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Methods::Research Design::Patient Selection Medical Subject Headings::Health Care::Health Services Administration::Patient Care Management::Delivery of Health Care Medical Subject Headings::Psychiatry and Psychology::Psychological Phenomena and Processes::Mental Processes::Thinking::Decision Making Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy::Immunization::Immunotherapy, Active::Vaccination Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis |
Issue Date: | 26-May-2021 |
Publisher: | MDPI |
Citation: | Dopazo J, Maya-Miles D, García F, Lorusso N, Calleja MÁ, Pareja MJ, et al. Implementing Personalized Medicine in COVID-19 in Andalusia: An Opportunity to Transform the Healthcare System. J Pers Med. 2021 May 26;11(6):475. |
Abstract: | The COVID-19 pandemic represents an unprecedented opportunity to exploit the advantages of personalized medicine for the prevention, diagnosis, treatment, surveillance and management of a new challenge in public health. COVID-19 infection is highly variable, ranging from asymptomatic infections to severe, life-threatening manifestations. Personalized medicine can play a key role in elucidating individual susceptibility to the infection as well as inter-individual variability in clinical course, prognosis and response to treatment. Integrating personalized medicine into clinical practice can also transform health care by enabling the design of preventive and therapeutic strategies tailored to individual profiles, improving the detection of outbreaks or defining transmission patterns at an increasingly local level. SARS-CoV2 genome sequencing, together with the assessment of specific patient genetic variants, will support clinical decision-makers and ultimately better ways to fight this disease. Additionally, it would facilitate a better stratification and selection of patients for clinical trials, thus increasing the likelihood of obtaining positive results. Lastly, defining a national strategy to implement in clinical practice all available tools of personalized medicine in COVID-19 could be challenging but linked to a positive transformation of the health care system. In this review, we provide an update of the achievements, promises, and challenges of personalized medicine in the fight against COVID-19 from susceptibility to natural history and response to therapy, as well as from surveillance to control measures and vaccination. We also discuss strategies to facilitate the adoption of this new paradigm for medical and public health measures during and after the pandemic in health care systems. |
URI: | http://hdl.handle.net/10668/4414 |
metadata.dc.relation.publisherversion: | https://www.mdpi.com/2075-4426/11/6/475/htm |
metadata.dc.identifier.doi: | 10.3390/jpm11060475 |
ISSN: | 2075-4426 (Online) |
Appears in Collections: | 01- Artículos - Consejería de Salud y Consumo 01- Artículos - FPS. Fundación Pública Andaluza Progreso y Salud 01- Artículos - Hospital de Valme 01- Artículos - Hospital Reina Sofía 01- Artículos - Hospital San Cecilio 01- Artículos - Hospital Virgen del Rocío 01- Artículos - IBIS. Instituto de Biomedicina de Sevilla 01- Artículos - ibsGRANADA. Instituto de Investigación Biosanitaria de Granada 01- Artículos - IMIBIC. Instituto Maimónides de Investigación Biomédica de Córdoba |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Dopazo_ImplementingPersonalized.pdf | Revisión | 976 kB | Adobe PDF | View/Open |
This item is protected by original copyright |
This item is licensed under a Creative Commons License